NOD2 and chronic obstructive pulmonary disease: Therefore, it can be hypothesized that in IBD patients with PM the NOD2 mutation might not only lead to altered inflammation in the gut, but also on the lung surface, especially because NOD2 mutations were also described in the pathogenesis of another inflammatory pulmonary disease—chronic obstructive pulmonary disease (COPD) [79].